Anchyra Partners
GSK icon

Anchyra Partners’s GSK GSK Stock Holding History

Anchyra Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$326K Buy
6,770
+1,248
+23% +$63.7K 0.07% 260
2026
Q2 		$289K Buy
5,522
+18
+0.3% +$952 0.07% 247
2026
Q1 		$304K Sell
5,504
-32
-0.6% -$1.73K 0.09% 205
2025
Q4 		$271K Buy
+5,536
New +$258K 0.08% 211

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $46.6B AUM 32.12% 1-Year Est. Return

Anchyra Partners's GSK Position: Q3 2026 in Review

Anchyra Partners increased its GSK (GSK) stake by 23% in Q3 2026, buying an estimated $63.7K and bringing the position to 6,770 shares worth $326K. The position accounts for 0.07% of the portfolio, ranked #260.

Anchyra Partners first reported a position in GSK in Q4 2025 and has held it in 4 quarters since. 854 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Anchyra Partners held 6,770 shares of GSK worth $326K as of Q3 2026.
  • Anchyra Partners bought 1,248 GSK shares in Q3 2026, an estimated $63.7K.
  • GSK made up 0.07% of Anchyra Partners's portfolio in Q3 2026, its #260 holding.
  • Anchyra Partners first reported a position in GSK in Q4 2025 and has held it in 4 quarters since.
  • 854 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.